Germline variants in angiogenesis-related genes contribute to clinical outcome in head and neck squamous cell carcinoma

HIGHLIGHTS

• who: Dorota Butkiewicz and collaborators from the Center for Translational Research and Molecular Biology of Cancer, Maria Sku0142odowska-Curie National have published the research work: Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma, in the Journal: Cancers 2022, x of /2022/
• what: This study shows that the FGF2 PDGFRA PDGFRB MMP2 and TIMP2 variants may contribute to treatment failure and poor prognosis in HNSCC. The authors aimed to evaluate the possible association between a panel of 19 variants in the FGF2, FGFR2, PDGFB, PDGFRA, PDGFRB, MMP2 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.